Int'l Pharma & Device Compliance Congress XIII Agenda and Brochure Now Available
  • Sponsored by ETHICS, the International Society of Healthcare Compliance Professionals
  • Media Partners: Policy & Medicine Compliance Update and Rx Data News
  • April 8 - 10, 2019
  • Onsite at the Grand Hyatt Athens Athens, Greece
  • www.InternationalPharmaCongress.com
PRESS RELEASE
Phone: 800-503-8171
Email: registration@hcconferences.com
Website: www.InternationalPharmaCongress.com
AGENDA AND BROCHURE
NOW AVAILABLE
Click here to view the agenda.
Click here to view the brochure.

EARLY BIRD REGISTRATION
- SAVE UP TO €400 -
Register by February 15, 2019 and save up to €400.
Click here to register.

ATHENS, GREECE -- PHARMA UPDATE NEWS SERVICE™ -- JANUARY 23, 2019: The Thirteenth International Pharmaceutical and Medical Device Compliance Congress, www.InternationalPharmaCongress.com, will be held April 8 - 10, 2019 at the Grand Hyatt Athens in Athens, Greece.

KEYNOTE SPEAKERS

Julie Bonhomme
EFPIA Legal & Compliance Director, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

Rachel Cooper, LLB, MSc
Director, Pharmaceuticals & Healthcare Programme, Transparency International UK, Former Head, Government Relations, World Vision UK, Former Vice Consul, British Embassy, Copenhagen, Deputy Head of Mission, British Embassy, Bratislava, Deputy High Commissioner, Freetown, London, UK

Holger Diener
Managing Director, Association of Voluntary Self-Regulation for the Pharmaceutical Industry ("FSA"), Member, Ethics and Compliance Committee and Vice Chair, Code Committee, EFPIA, Member, IFPMA Code Compliance Network, Berlin, Germany

Robert I. Dodge, JD
Assistant Director, FCPA Unit, US Securities & Exchange Commission, Former Assistant U.S. Attorney, US Attorney's Office, Western District of Michigan, Former Assistant Section Chief, Environmental Defense Section, US Department of Justice, Washington, DC, USA

Abhiroop Gandhi
Trust and Compliance Officer, Verily Life Sciences (an Alphabet company), Former Vice President, Corporate Compliance, Mallinckrodt, San Francisco, CA, USA

José F. Zamarriego Izquierdo, MBA, PhD
Director, Code of Practice Surveillance Unit, Farmaindustria, Chair, EFPIA's Code Committee, Coordinator, EFPIA e4ethics Initiative, Chairman, IFPMA's Code Complaint Procedure Appeal Group, Madrid, Spain

Sofie Melis
Senior Manager, Ethics and Compliance, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Geneva, Switzerland

Bastian Obermayer
Reporter, Investigative Unit, Süddeutsche Zeitung, Co-author, The Panama Papers: Breaking the Story of How the Rich and Powerful Hide Their Money, Awardee, 2017 Pulitzer Prize in Journalism, Munich, Germany

Guido Palazzo, PhD
Professor of Business Ethics, Department of Strategy, Globalization and Society, University of Lausanne, Lausanne, Switzerland

Piergiorgio Pepe, MA EU Law
President, Quantum Ethics, Ethics and Compliance Lecturer, SciencesPo, Former Compliance Director Western Europe & Canada, AbbVie, Former Director, Compliance & Ethics EMEA, Bristol-Myers Squibb, Paris, France

Rami A. Rajab
Chairman, Mecomed Medical Technology, Association Middle East & Africa (MECOMED), Chairman, LIFE (LivaNova International Fellowship), International Corporate Social Responsibility, Former VP Market Access, Emerging Markets, LivaNova, Maidenhead, UK

Harout Semerjian, MBA
Executive Vice-President & Chief Commercial Officer, Ipsen, Former Senior Vice President and Global Launch Lead, Ribociclib, Novartis Oncology, New York, NY, USA

Heather Simmonds
Director, Prescription Medicines Code of Practice Authority, London, United Kingdom

Christopher L. White, JD
Chief Operating Officer & General Counsel, Advanced Medical Technology Association (AdvaMed), Washington, DC, USA

FEATURING PRECONFERENCE SESSIONS
  • Precon I: A Workshop on Practical Case Studies & Exercises in Ethics & Compliance
  • Precon II: Advanced Investigations

PLENARY SESSIONS
  • International Pharma Congress Vision and Overview
  • Keynote Address: Pharma Executive
  • Compliance Issues Raised by Pharma & Device New Business Models
  • Global Compliance Codes Update
  • Annual Chief Compliance Officer Roundtable
  • Keynote Address: Transparency International
  • Annual Anticorruption Roundtable
  • Update on the new French Sapin II Law
  • Annual FCPA Update Roundtable
  • Multi-jurisdictional Anticorruption Investigations & Prosecutions
  • Ethics and Compliance Keynote Address
  • The Emerging Role of Technology Companies in Life Science
  • IFPMA Global Compliance Updates
  • Transforming Compliance into a Profession
AND CONCURRENT MINI SUMMITS
  • Annual Medical Device Ethics & Compliance Roundtable
  • Digitalization of Compliance
  • Data Privacy, Consent Management and GDPR Update
  • Ethics & Compliance Issues in Patient Relationships
  • Annual Central and Eastern Europe (CEE) Compliance Update
  • Annual Middle East Africa (MEA) Compliance Update
  • EU & US Whistleblower Updates
  • Using Risk Assessment to Design Compliance Programs
  • Analytics with Reference to Transparency & Monitoring
  • Improving the Future of Compliant HCP Engagements
  • Reducing FCPA Exposure through Better Use of Data
  • Compliance Issues in Manufacturer Relationships with Foundations
  • Behavioral Science to Enhance Effectiveness of Compliance Programs
  • Third Party Due Diligence and Management
  • Structuring an Efficient Digital Compliance Framework
  • Auditing and Monitoring Workgroup
  • R&D and Clinical Trials Compliance Workgroup
  • Working with in-company Business Partners Workgroup

FEATURED FACULTY

Pablo Rojas Abad, LLM
Manager, Legal and Compliance, MedTech Europe, Brussels, Belgium

David Andersen
Partner, Pharmaceuticals and Life Sciences, PwC, London, UK

Yogesh Bahl, CPA, MBA
Managing Director, Alix Partners, New York, NY

Michael Bartke, PhD
Director Ethics & Compliance, Alexion, Former Director Compliance Management, Daiichi Sankyo Europe GmbH, Strategic Committee, ETHICS, Munich, Germany

Ann Beasley, JD
Director, Life Sciences Regulatory & Compliance, Navigant; Former Senior VP, CCO, Biogen, Boston, MA, USA

Enno Behrendt
Compliance Officer, Siemens Healthcare GmbH, General Legal Counsel, evosoft GmbH, Erlangen, Germany

Thomas W. Beimers, JD
Partner, Hogan Lovells; Former Senior Counsel for Administrative and Civil Remedies, Office of the Inspector General, Department of Health and Human Services; Minneapolis, MN, USA

Maike Bermüller
Senior Legal Counsel and Global Healthcare Compliance Officer, Boehringer Ingelheim, Frankfurt Am Main, Germany

Chris van Bronckhorst
Global Compliance Director, IQVIA, The Hague, Netherlands

Ryan Burger, MS
Head, Global Assurance & Reporting Services, Astra Zeneca, Former Manager, Aggregate Spend and Transparency Reporting, Daiichi Sankyo, Former Manager, Transparency Operations, Sanofi, Former Manager, Disclosure Reporting, Pfizer, New York, NY

Keith Burn
Global Investigations Director, Ipsen, Former Associate Investigator, Parliamentary and Health Service Ombudsman, NHS, Former Detective Constable, London Metropolitan Police, Amersham, Buckinghamshire, UK

Antonio Cavallaro
Compliance Officer Merck Serono Italy, Former Head of Compliance Takeda Italy, Rome, Italy

Matt Combs
Services Development Director, IQVIA, Former Strategic Business Director, Qforma, London, UK

Peter Dieners, Esq.
Partner and Head, Global Healthcare and Life Sciences Group, Clifford Chance, Co-chair, Legal Affairs Focus Group (LA FG), EUCOMED, Co-chair, Compliance Network (CN), EUCOMED, Düsseldorf, Germany

Julien Durand, MBA, PhD
Executive Director Compliance & Ethics, Amgen, Former Chief Privacy Officer and Global Technology Compliance Head, AstraZeneca, Zürich, Switzerland

Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK

Karen Eryou
Head, Ethics & Compliance Programs, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium

George Fife
Partner, Fraud Investigation & Dispute Services, EY, Former Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Paris, France

Carlo Geninazza
Senior Manager, CAWECO GmbH, Munich, Germany

Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA

Betania Glorio
Global Compliance Officer Healthcare, Merck KGaA, Former Senior Director, Legal and Compliance EMEA, Horizon, Former Senior Counsel, Regional Compliance Director, EUCAN, Pfizer, Darmstadt, Germany

Cecile Gousset
Head of Compliance Risk Assessment, Policies & Education, Global Ethics & Business Integrity, Sanofi, Paris, France

Tom Gregory, MBA
Partner, Forensic & Integrity Services, EY, Atlanta, USA

Ulf H. Grundmann
Partner, FDA and Life Sciences, King & Spalding LLP, Frankfurt am Main, Germany

Glen Haith, JD
Global Head, Integrity & Compliance Pharma Medical Affairs, Novartis Pharmaceuticals, Former Associate Vice President and Chief Compliance Officer, ImClone Systems, Basel, Switzerland

Thomas K. Hauser, MA HSG, MSJ
Director, Life Sciences Governance, Risk Management and Compliance Practice, Navigant; Treasurer, ETHICS; Former Global CCO, Siemens Healthcare, London, UK

Gérald Hucky
Head Group Compliance, Sonova Group, Former Compliance Audit Manager, NameZimmer Biomet, Zürich, Switzerland

Brett Hudson, MBIM
Head of Group I&C Group Integrity & Compliance, Novartis, Former Global Program Director - Integrity & Compliance, Sandoz, Basel, Switzerland

Arielle Hung, LLM
Compliance Counsel, LE-CS Compliance Programs and Support, Merck KGaA, Darmstadt, Germany

Franziska Janorschke
Global Head Business Practices Office, Novartis International AG, Basel, Switzerland

Carl Judge
Partner, Forensic & Integrity Services, EY, London, UK

Timur Khasanov-Batirov, LLM
Compliance Officer, Russia, CIS & Romania, Dr. Reddy's Laboratories, Author, Compliance Man of Integrity Corp. and Integrity Corp. 50 Tips for Your Compliance, Program in the Post-Soviet States, Moscow, Russian Federation

Maria Khoury, MBA, PharmD
Compliance Officer Levant, Roche, Chair, Lebanese Group of International Pharmaceutical Companies and Iraq LAWG (Local Area Working Group), Beirut, Lebanon

Anita Kyung-Hee Kim-Reinartz
Partner, Forensic & Integrity Services, EY, Düsseldorf, Germany

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA

Tomasz Kruk
Head of Compliance, Vifor Pharma, Switzerland

Julie Kudyba
Head International Ethics & Compliance, Shire, Former Global Head Integrity & Compliance, Alcon, Former Global Privacy Officer, Novartis Pharma AG, Fort Worth, TX, USA

Chrystel Lanxade
Regional Compliance Officer, Europe Middle East Africa, Alcon; Former Legal Counsel, Leem; Former Corporate Counsel, Pfizer, Cointrin, Canton of Geneva, Switzerland

Aline Lautenberg
General Counsel and Director Legal & Compliance, MedTech Europe, Brussels, Belgium

Edoardo Lazzarini, PhD
Healthcare Compliance Consultant, Former EuCan Ethics & Compliance Initiatives Director, Takeda Pharmaceuticals, Former Compliance Officer EMEA (Europe, Middle East & Africa), Zimmer Biomet, Milan, Italy

Martina Leposa
HealthCare Compliance Officer, Janssen-Cilag Ltd. (a Johnson & Johnson company), Chair, Compliance Committee, Association of Innovative Pharmaceutical Manufacturers, Budapest, Hungary

Michael K. Loucks, JD
Partner, Skadden Arps LLP, Former Acting United States Attorney, District of Massachusetts, US Department of Justice, Washington, DC, USA

Abdul Luheshi, MBA
Executive Director, Global Operations, Ethics & Compliance, Astellas Pharma EMEA, Former Vice President, Health Care Compliance, Johnson & Johnson, Chertsey, UK

Paul J. Melling, JD
Founding Partner, Baker & McKenzie -- CIS, Limited, Moscow, Russia

Laetitia Ducroquet Minel
Director, Ethics & Compliance, Ipsen, Boulogne-Billancourt, France

Laura Nassar, PharmD
Head of Compliance Middle East, Roche Pharmaceuticals, Chair, Compliance Committee, Pharmaceutical Research, and Manufacturers Association, Gulf (PhRMAG), Beirut, Lebanon

Wim Nauwelaerts, JD, LLM
Partner, Sidley Austin LLP, Brussels, Belgium

Marcelo Nogueira
Latin América, Central America and Canada Regional Compliance Monitor, Former Compliance Officer Brasil, Amgen, Former Compliance Officer Brasil, Sandoz, Former Legal Counsel and Compliance Officer, Gilead Sciences, Sao Paulo, Brazil

Michael O'Connor, MS
Vice President of Compliance Technology, Porzio Life Sciences, LLC, Former Global Head Compliance and Ethics Operations, Alexion, Former Executive Director, Global Head, IS Business Consulting, Boehringer Ingelheim, New York, NY

Minal Patel
Health Care Compliance Officer, Pharma and Consumer, Johnson & Johnson, Johannesburg Area, South Africa

Marie-Claire Pickaert
Former Deputy Director General, Chief Financial Officer and Ambassador to the Medical Communities, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

Madina Plieva, PhD
Legal and Compliance Head, Russia, Bristol-Myers Squibb, Former Legal Director, Association of International Pharmaceutical Manufacturers (AIPM), Former Head of Legal Department, Kutafin Moscow State Law Academy, Moscow, Russia

Mario Prohasky
Global Compliance Consultant, IQVIA, London, UK

Ariadna Quesada, MSJ
Law, Ethics and Compliance Officer, The Netherlands, AbbVie; Former Compliance Manager International, MicroPort Orthopedics Inc., Amsterdam, Netherlands

Tjerk Schlufter
Senior Vice President Compliance, Fresenius SE; Former General Counsel, Imaging & Therapy Systems, Siemens AG, Frankfurt Am Main, Germany

Antje Petersen Schmalnauer, JD, LLM
Group General Counsel, Sonova Group, Former Interim VP Legal and General Counsel, Kautex Textron, Former Global Privacy and Data Protection Officer, Biomet, Cologne, Germany

Leonardo Silva, LLM
Global Compliance Officer, Head of Global Compliance, Ferring, Former Head of Compliance, Acino Group, Former Compliance Director, Emerging Markets, Takeda, St. Prex, Switzerland

Ruth Sturm
Head of Compliance EMEA, SIEMENS Healthineers, Erlangen, Germany

Michele Tagliaferri, JD
Partner and Lead, Investigations and Compliance Team, Sidley Austin LLP, Brussels, Belgium

Trudy Tan
Global Head Integrity & Compliance, Pharma, Novartis; Former VP Compliance North America, AstraZeneca; Basel, Switzerland

Evgeny Tilezhinsky, MBA, PhD
Law and Compliance Lead for the Central and Eastern Europe, Bristol-Myers Squibb, Uxbridge, Middlesex, UK

Eirini Tsotra, MS, CIPP/E, CIPM, CISA
Director, Privacy & Data Protection, Ferring International Centre SA, St-Prex, Switzerland

Tamara Tubin
International Compliance Director, Corporate Compliance, Wright Medical Group N.V., Vice Chair, Ethics & Compliance Committee, MedTech Europe, Member, Strategic Committee, ETHICS, Zürich, Switzerland

Satnam Tumani, LLB
Partner, Kirkland & Ellis International LLC, Former Head of Bribery & Corruption, Serious Fraud Office, London, UK

Katharina Weghmann, MBA, EdD
Associate Partner, Forensic & Integrity Services, EY, Düsseldorf, Germany

Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland

Niels Wohlwend, Master of Law (lic iur), MAES
Senior Director Healthcare Compliance (HCC) Europe & Canada, Celgene, Member, WFPIA Ethics & Compliance Committee, Former Global Head of Compliance, ACINO, Former Head of Compliance APAC, LATAM and MEA, Mundipharma, Boudry, Canton of Neuch‚tel, Switzerland

Elisabethann Wright, LLB
Partner, Hogan Lovells, Former, Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium

2019 GLOBAL PHARMA COMPLIANCE CONGRESSES

THIRTEENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL
DEVICE COMPLIANCE CONGRESS

Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partners: Policy & Medicine Compliance Update and Rx Data News
April 8 - 10, 2019
Grand Hyatt Athens
Athens, Greece
www.International PharmaCongress.com
NINTH ASIA PACIFIC
PHARMACEUTICAL AND MEDICAL
DEVICE COMPLIANCE CONGRESS

Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS)
Media Partners: Policy & Medicine Compliance Update
September, 2019
Shanghai, China
www.Asian PharmaCongress.com
TWENTIETH ANNUAL PHARMACEUTICAL AND
MEDICAL DEVICE COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs, Policy & Medicine Compliance Update and Rx Data News
November 6 - 8, 2019
Mandarin Oriental
Washington, DC
www.PharmaCongress.com

SPONSORED BY:


CO CHAIRS

Dante Beccaria
Senior Vice President, Global Compliance Officer, Head of Ethics & Business Integrity Department, Sanofi, Paris, France


Stephen Nguyen Duc
Global Head of Ethics & Compliance, Medday Pharmaceuticals, Board Member, Strategic Committee International Society of Healthcare, Ethics, and Compliance Professionals (ETHICS), Rungis, France


Suzanne Durdevic, LLM
Former Senior Director, General Counsel Europe, Boston Scientific International, Member, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Paris, France


Dominique Laymand, Esq.
Executive Vice President, Chief Ethics and Compliance Officer, Ipsen; Honorary President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France


Roeland Van Aelst
Regional Vice President -- HCCO MD&D EMEA & Canada, Office Health Care Compliance and Privacy, Johnson & Johnson, Chairman, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Compliance Network, Brussels, Belgium

GRANTORS
DIAMOND


SILVER




BRONZE
















MEDIA PARTNER:




CONTINUING EDUCATION CREDITS:
Accounting Professionals: Approved for up to 18.5 NASBA CPE credits.

Attorneys: Pending approval for Pennsylvania CLE Credits.

Compliance Professionals: This education activity has been submitted to the Compliance Certification Board (CCB)&3174; and is currently pending their review for approval of CCB CEUs.

Click here for more information.

STAY CONNECTED




Tweet using #PharmaCongress

THE CONGRESS IS


PAST GLOBAL PHARMA COMPLIANCE CONGRESSES

2007 - Brussels


2008 - Paris


2009 - Rome


2010 - Berlin


2011 - Istanbul


2011 - Singapore


2012 - Budapest


2012 - Shanghai


2012 - S„o Paulo


2013 - Madrid


2013 - Kuala Lumpur


2014 - Dubai


2014 - Mexico City


2014 - Shanghai


2015 - Manila


2016 - Warsaw


2017 - Lisbon


2018 - Vienna

ONSITE ATTENDANCE
Simply register, travel to the conference city and attend in person.

Pros: subject matter immersion; professional networking opportunities; faculty interaction






We subscribe to the HONcode principles of the HON Foundation. Click to verify.





CONGRESS REGISTRATION

For Congress registration information, visit www.internationalpharmacongress.com/registration/, email registration@hcconferences.com, or call 800-503-8171.


CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
For sponsorship and exhibit information, visit www.internationalpharmacongress.com/promotional-opportunities/, or contact Justin Sorensen, Exhibit Manager, at 206-452-0609 phone, 206-319-5303 fax, or exhibits@hcconferences.com.